Hjem › Type 2-diabetes › Connecticut
Type 2-diabetes kliniske forsøg i Connecticut
14 studier for Type 2-diabetes søger deltagere på steder i Connecticut.
Byer i Connecticut
Officiel studietekst (engelsk)
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Chase Medical Research LLC, Waterbury
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07817251EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Cardiology Physicians of Fairfield County - Bridgeport, Bridgeport
- CMR of Greater New Haven, LLC, Hamden
- Cardiology Associates of Fairfield County, Stamford
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07064473A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- New England Research Associates, LLC, Bridgeport
- CMR of Greater New Haven, LLC, Hamden
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07282600Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Yale University, New Haven
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 11. sep. 2026 · NCT07271186A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Bridgeport
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07662213A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Yale School of Medicine, New Haven
RekruttererFase 3
Alder 10 til 18 · Alle køn · Opdateret 9. sep. 2026 · NCT07282613A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Bridgeport
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 31. aug. 2026 · NCT07662044A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Yale Diabetes Research, New Haven
RekruttererFase 3
Alder 10 til 17 · Alle køn · Opdateret 7. aug. 2026 · NCT06739122Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
- Yale, New Haven
Rekrutterer
Alder 14 til 75 · Alle køn · Opdateret 3. aug. 2026 · NCT07579702Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life
- Yale University, New Haven
RekruttererFrivillige med god helbredstilstand velkomne
Alder 40 og opefter · Alle køn · Opdateret 17. jun. 2026 · NCT07376655Ultrasound Effects on Glycemic Control in T2DM
- Yale-New Haven Hospital, New Haven
Rekrutterer
Alder 21 til 75 · Alle køn · Opdateret 27. jan. 2026 · NCT05354947Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access
- Fair Haven Community Health Care (FHCHC), New Haven
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 3. dec. 2025 · NCT06658067Diabetes Learning in Virtual Environments Just in Time for Community Reentry
- University of Connecticut, Storrs
- University of Connecticut, Storrs Mansfield
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 28. jul. 2025 · NCT05286892Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM)
- Yale New Haven Hospital (YNHH) Research Unit (HRU), New Haven
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 til 60 · Alle køn · Opdateret 14. jan. 2025 · NCT05776563Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.